Vascular aging represents the common pathological basis of aging-related diseases, with vascular smooth muscle cells (VSMCs) senescence playing a pivotal role. P300/CBP-associated factor (PCAF), a transcriptional coactivator linked to diverse physiological processes, has an undefined role in VSMCs aging. This study investigated PCAF's function in VSMC senescence and its underlying mechanisms. Using siRNA adenovirus to downregulate PCAF and angiotensin II (AngII) to induce senescence, we assessed β-galactosidase activity, senescence-associated secretory phenotypes (SASP), and cell cycle proteins (p53, p21, p16). Transcriptomic analysis revealed PCAF's association with oxidative stress and the Nrf2-ARE pathway. Results demonstrated that PCAF downregulation significantly attenuated VSMCs senescence and AngII-induced oxidative stress by enhancing Nrf2-ARE pathway activity. Crucially, Nrf2 silencing reversed these protective effects. In conclusion, PCAF inhibition mitigates VSMCs senescence via Nrf2-ARE-mediated antioxidant activation, identifying PCAF as a promising therapeutic target for vascular aging.
PartridgeLDeelenJSlagboomPE. Facing up to the global challenges of ageing. Nature2018; 561: 45–56.
2.
GrunewaldMKumarSSharifeH, et al.Counteracting age-related VEGF signaling insufficiency promotes healthy aging and extends life span. Science (New York, N.Y.)2021; 373: eabc8479.
3.
CaoQWuJWangX,et al.Noncoding RNAs in vascular aging. Oxid Med Cell Longev2020; 2020: 7914957.
4.
VilchezDSaezIDillinA. The role of protein clearance mechanisms in organismal ageing and age-related diseases. Nat Commun2014; 5: 5659.
5.
ChildsBGGluscevicMBakerDJ, et al.Senescent cells: an emerging target for diseases of ageing. Nat Rev Drug Discov2017; 16: 718–735.
6.
StojanovićSDFuchsMKunzM, et al.Inflammatory drivers of cardiovascular disease: molecular characterization of senescent coronary vascular smooth muscle cells. Front Physiol2020; 11: 520.
7.
KhorESWongPF. The roles of MTOR and miRNAs in endothelial cell senescence. Biogerontology2020; 21: 517–530.
8.
GeorgilisAGilJS. Controlling secretion to limit chemoresistance. Genes Dev2016; 30: 1791–1792.
9.
YangDXiaoCLongF, et al.Fra-1 plays a critical role in angiotensin II-induced vascular senescence. FASEB J2019; 33: 7603–7614.
10.
LiDJHuangFNiM, et al.Α7 nicotinic acetylcholine receptor relieves angiotensin II-induced senescence in vascular smooth muscle cells by raising nicotinamide adenine dinucleotide-dependent SIRT1 activity. Arterioscler, Thromb, Vasc Biol2016; 36: 1566–1576.
11.
QiuLXuCXiaH, et al.Downregulation of p300/CBP-associated factor attenuates myocardial ischemia-reperfusion injury via inhibiting autophagy. Int J Med Sci2020; 17: 1196–1206.
12.
LuYFXuXPLuXP, et al.SIRT7 Activates p53 by enhancing PCAF-mediated MDM2 degradation to arrest the cell cycle. Oncogene2020; 39: 4650–4665.
13.
LiuTWangXHuW, et al.Epigenetically down-regulated acetyltransferase PCAF increases the resistance of colorectal cancer to 5-fluorouracil. Neoplasia2019; 21: 557–570.
14.
FeiHJZuLDWuJ, et al.PCAF Acts as a gastric cancer suppressor through a novel PCAF-p16-CDK4 axis. Am J Cancer Res2016; 6: 2772–2786.
15.
QiuLXuCChenJ, et al.Downregulation of the transcriptional co-activator PCAF inhibits the proliferation and migration of vascular smooth muscle cells and attenuates NF-κb-mediated inflammatory responses. Biochem Biophys Res Commun2019; 513: 41–48.
16.
MccarthyCGWenceslauCFWebbRC,et al.Novel contributors and mechanisms of cellular senescence in hypertension-associated premature vascular aging. Am J Hypertens2019; 32: 709–719.
17.
ZhangJYinZXuY, et al.Resolvin e1/ChemR23 protects against hypertension and vascular remodeling in angiotensin II-induced hypertensive mice. Hypertension (Dallas, Tex.: 1979)2023; 80: 2650–2664.
18.
BaiHYMinLJShanBS, et al.Angiotensin II and amyloid-β synergistically induce brain vascular smooth muscle cell senescence. Am J Hypertens2021; 34: 552–562.
19.
GanLLiuDLiuJ, et al.CD38 Deficiency alleviates ang II-induced vascular remodeling by inhibiting small extracellular vesicle-mediated vascular smooth muscle cell senescence in mice. Signal Transduct Target Ther2021; 6: 223.
20.
BaiHYLiHZhouX, et al.At2 receptor stimulation inhibits vascular smooth muscle cell senescence induced by angiotensin II and hyperglycemia. Am J Hypertens2022; 35: 884–891.
21.
QiuLXuCJiangH, et al.Cantharidin attenuates the proliferation and migration of vascular smooth muscle cells through suppressing inflammatory response. Biol Pharm Bull2019; 42: 34–42.
22.
DecaprioJKohlTO. Immunoprecipitation. Cold Spring Harb Protoc2020; 2020: 10–1101.
23.
LeongDPJosephPGMckeeM, et al.Reducing the global burden of cardiovascular disease, part 2: prevention and treatment of cardiovascular disease. Circ Res2017; 121: 695–710.
24.
RothGAJohnsonCAbajobirA, et al.Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol2017; 70: 1–25.
KimYMEYounSWSudhaharV, et al.Redox regulation of mitochondrial fission protein drp1 by protein disulfide isomerase limits endothelial senescence. Cell Rep2018; 23: 3565–3578.
28.
Carrillo-SepulvedaMAMaddieNJohnsonCM, et al.Vascular hyperacetylation is associated with vascular smooth muscle dysfunction in a rat model of non-obese type 2 diabetes. Mol Med (Cambridge, Mass.)2022; 28: 30.
29.
OkunoKCicaleseSElliottKJ, et al.Targeting molecular mechanism of vascular smooth muscle senescence induced by angiotensin II, a potential therapy via senolytics and senomorphics. Int J Mol Sci2020; 21: 6579.
30.
MiyaoMCicaleseSKawaiT, et al.Involvement of senescence and mitochondrial fission in endothelial cell pro-inflammatory phenotype induced by angiotensin II. Int J Mol Sci2020; 21: 3112.
31.
MalteseGPsefteliPMRARizzoB, et al.The anti-ageing hormone klotho induces nrf2-mediated antioxidant defences in human aortic smooth muscle cells. J Cell Mol Med2017; 21: 621–627.
32.
van DeursenJM. The role of senescent cells in ageing. Nature2014; 509: 439–446.
33.
SchossererM. The role and biology of senescent cells in ageing-related tissue damage and repair. Mech Ageing Dev2022; 202: 111629.
34.
SharplessNESherrCJ. Forging a signature of in vivo senescence. Nat Rev Cancer2015; 15: 397–408.
35.
BirchJGilJS. Senescence and the SASP: many therapeutic avenues. Genes Dev2020; 34: 1565–1576.
36.
HeSSharplessNE. Senescence in health and disease. Cell2017; 169: 1000–1011.
37.
MidhaAPanHAbarcaC, et al.Unique human and mouse β-cell senescence-associated secretory phenotype (SASP) reveal conserved signaling pathways and heterogeneous factors. Diabetes2021; 70: 1098–1116.
38.
BarnesPJBakerJDonnellyLE. Cellular senescence as a mechanism and target in chronic lung diseases. Am J Respir Crit Care Med2019; 200: 556–564.
39.
MilanovicMFanDNYBelenkiD, et al.Senescence-associated reprogramming promotes cancer stemness. Nature2018; 553: 96–100.
40.
ChenLYangRQiaoW, et al.1,25-dihydroxyvitamin D exerts an antiaging role by activation of nrf2-antioxidant signaling and inactivation of p16/p53-senescence signaling. Aging Cell2019; 18: e12951.
41.
RyszJFranczykBRysz-GórzyńskaM,et al.Ageing, age-related cardiovascular risk and the beneficial role of natural components intake. Int J Mol Sci2021; 23: 83.
42.
HainesDDJuhaszBTosakiA. Management of multicellular senescence and oxidative stress. J Cell Mol Med2013; 17: 936–957.
43.
OmidifarNMoghadamiMMousaviSM, et al.Trends in natural nutrients for oxidative stress and cell senescence. Oxid Med Cell Longev2021; 2021: 7501424.
44.
FinkelTHolbrookNJ. Oxidants, oxidative stress and the biology of ageing. Nature2000; 408: 239–247.
45.
VatnerSFZhangJOydanichM, et al.Healthful aging mediated by inhibition of oxidative stress. Ageing Res Rev2020; 64: 101194.
46.
MecocciPBoccardiVCecchettiR, et al.A long journey into aging, brain aging, and Alzheimer's disease following the oxidative stress tracks. J Alzheimer's Dis: JAD2018; 62: 1319–1335.
47.
ZhangHDaviesKJAFormanHJ. Oxidative stress response and nrf2 signaling in aging. Free Radic Biol Med2015; 88: 314–336.
48.
YuCXiaoJH. The keap1-nrf2 system: a mediator between oxidative stress and aging. Oxid Med Cell Longev2021; 2021: 6635460.
49.
ChungSYoonHEKimSJ, et al.Oleanolic acid attenuates renal fibrosis in mice with unilateral ureteral obstruction via facilitating nuclear translocation of nrf2. Nutr Metab (Lond)2014; 11: 2.
50.
WangYWangBDuF, et al.Epigallocatechin-3-gallate attenuates oxidative stress and inflammation in obstructive nephropathy via NF-κb and nrf2/HO-1 signalling pathway regulation. Basic Clin Pharmacol Toxicol2015; 117: 164–172.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
